Skip to main content
Equibles
CGON logo

CGON · CG Oncology, Inc. · Held by Funds

Track CGON — free

Use CGON with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CGON.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$62.24 +0.31 (+0.50%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$5.52B
Shares
88.64M
Volume · Oct 21 530.15K Avg daily vol (3M) 872.01K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of CGON by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 16.60% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.61% 2,316,639
Index ETFs 13.99% 12,397,803
Active ETFs 0.85% 750,669
Active funds 21.72% 19,255,623
Unclassified 0.21% 187,894
All registered funds 39.38% 34,908,628
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding CGON

331 fund positions
Fund Balance Value % of Fund Open
VANGUARD HEALTH CARE FUND 2,860,428 $203,633,869 0.53%
T. Rowe Price Capital Appreciation Fund 2,574,868 $182,944,371 0.26%
VANGUARD TOTAL STOCK MARKET INDEX FUND 2,383,134 $169,321,671 0.01%
iShares Russell 2000 ETF 1,894,091 $134,575,166 0.16%
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,812,932 $128,808,819 1.20%
VANGUARD SMALL-CAP INDEX FUND 1,720,068 $122,210,831 0.06%
T. Rowe Price New Horizons Fund, Inc. 1,114,695 $79,199,080 0.54%
VANGUARD EXTENDED MARKET INDEX FUND 860,026 $61,104,847 0.06%
Fidelity Small Cap Index Fund 806,808 $57,436,662 0.17%
Fidelity Small Cap Growth Fund 797,441 $56,769,825 0.65%
T. Rowe Price Mid-Cap Growth Fund, Inc. 744,793 $52,917,543 0.23%
iShares Russell 2000 Growth ETF 681,220 $48,400,681 0.31%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund 658,981 $46,820,600 0.48%
JNL/T. Rowe Price Capital Appreciation Fund 593,262 $42,151,265 0.28%
Small Cap Growth Fund 554,416 $39,468,875 0.71%
VANGUARD SMALL-CAP VALUE INDEX FUND 544,588 $38,692,977 0.06%
VANGUARD SMALL-CAP GROWTH INDEX FUND 496,371 $35,267,160 0.08%
Fidelity Small Cap Growth K6 Fund 480,339 $34,195,333 0.74%
VANGUARD EXPLORER FUND 467,276 $33,265,378 0.15%
Select Health Care Portfolio 500,000 $31,145,000 0.54%
T. Rowe Price Health Sciences Fund, Inc. 437,973 $31,117,982 0.26%
iShares Biotechnology ETF 407,369 $28,943,567 0.32%
Eventide Healthcare & Life Sciences Fund 366,397 $26,032,507 1.46%
AB Small Cap Growth Portfolio 356,146 $25,304,173 0.81%
Strategic Advisers Fidelity U.S. Total Stock Fund 363,530 $22,644,284 0.01%
Fidelity Extended Market Index Fund 354,294 $22,068,973 0.05%
T. Rowe Price Small-Cap Stock Fund, Inc. 304,793 $21,655,543 0.23%
LORD ABBETT DEVELOPING GROWTH FUND INC 299,175 $21,298,268 0.96%
Schwab U.S. Small-Cap ETF 329,010 $20,494,033 0.09%
AB DISCOVERY GROWTH FUND, INC. 279,127 $19,831,973 0.68%
VANGUARD RUSSELL 2000 INDEX FUND 303,759 $18,921,148 0.11%
VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO 255,838 $18,177,290 0.26%
T. Rowe Price Capital Appreciation Equity ETF 247,724 $17,600,790 0.24%
Fidelity Advisor Health Care Fund 228,000 $16,231,320 0.52%
Fidelity SAI Small-Mid Cap Momentum Index Fund 209,476 $14,912,596 0.36%
Putnam Small Cap Growth Fund 204,363 $14,519,991 0.43%
Franklin Small-Mid Cap Growth Fund 200,480 $14,272,171 0.41%
Franklin Small Cap Growth Fund 192,634 $13,713,614 0.55%
ClearBridge Small Cap Growth Fund 187,829 $13,371,547 0.70%
Penn Series Flexibly Managed Fund 181,542 $12,898,559 0.26%
Schwab Small-Cap Index Fund 179,343 $12,767,428 0.17%
Franklin Biotechnology Discovery Fund 174,532 $12,424,933 1.08%
T. Rowe Price Institutional Small-Cap Stock Fund 166,519 $11,831,175 0.24%
Fidelity Advisor Biotechnology Fund 157,700 $11,226,663 0.51%
T. Rowe Price Small-Cap Value Fund, Inc. 154,769 $10,996,337 0.10%
Fidelity Small Cap Discovery Fund 147,900 $10,529,001 0.46%
Master Small Cap Index Series 136,050 $9,666,353 0.16%
Federated Hermes MDT Small Cap Core Fund 133,323 $9,491,264 0.42%
EQ/AB Small Cap Growth Portfolio 133,146 $9,460,023 0.42%
Fidelity Series Small Cap Discovery Fund 129,200 $9,197,748 0.47%
Showing 1–50 of 331 positions
Key facts CIK 1991792 CUSIP 156944100 13F (30d) 19 filings 19 filers Visit website Investor relations